Focalin FDA Approval Status (2026) – Approved or Not?
FDA Regulatory Database

Is Focalin
FDA approved?

DrugStatusIndex.com provides a plain-English status page for Focalin, including FDA approval status, prescription classification, compounding context, pricing information, and regulatory notes.

FDA approved
FDA status
Medication / drug-name index candidate
Drug category
2026-05-04
Last reviewed
Drug status summary

Focalin

FDA approved

Focalin is included as a DrugStatusIndex entry based on the FDA Orange Book Product Name Index and should be reviewed before publishing.

Brand names
Focalin
Prescription status
Available by prescription or OTC depending on the specific FDA-approved product, labeling, and route.
Compounded status
Commercial FDA-approved product; verify exact product, route, and indication
Confusion level
Medium
FDA Approved Approved for commercial use in the US
Not Approved Not cleared by FDA for use
Investigational Under review or in clinical trials
Rx Only Prescription required — not OTC
FDA approval status

Focalin approval status and regulatory context

This page is structured for LPagery Pro and uses your CSV fields to create a consistent, scalable drug-status page that matches the current DrugStatusIndex.com home page design.

What DrugStatusIndex currently shows

Focalin is included as a DrugStatusIndex entry based on the FDA Orange Book Product Name Index and should be reviewed before publishing.

Regulatory note: Users should verify labeling, approved indications, route, dosage form, and current FDA guidance directly through official FDA resources.
FDA status
FDA approved
Drug category
Medication / drug-name index candidate
Prescription status
Available by prescription or OTC depending on the specific FDA-approved product, labeling, and route.
Availability note
Availability depends on prescription eligibility, OTC status, pharmacy supply, insurance coverage, and current market access.

Index review fields

Review status
Needs review
Last checked
2026-05-04
Published
No
Page URL
https://drugstatusindex.com/is-focalin-fda-approved/
Pricing and access

Focalin pricing information

Pricing can vary by dose, pharmacy, insurance coverage, manufacturer savings, coupon programs, market availability, and current supply conditions.

Retail estimate
$250-$400 brand / month

Estimated cash or retail pricing range when available.

Coupon estimate
$15-$60 generic dexmethylphenidate

Discount-card or pharmacy coupon estimate when available.

Pricing last checked
May 2026

Pricing data should be rechecked before making financial or treatment decisions.

Pricing summary

Focalin estimated cash pricing: $250-$400 brand / month. Discount/coupon estimate: $15-$60 generic dexmethylphenidate. Pricing varies by dose, quantity, pharmacy, location, insurance, and current savings programs.

Coverage and savings notes

Manufacturer savings: Manufacturer or patient-assistance savings may apply for brand/specialty products; generic drugs usually rely on pharmacy coupon pricing.

Insurance note: Coverage and prior authorization vary by plan, dose, pharmacy, and diagnosis.

Sources and verification

Verify Focalin directly with trusted source material

DrugStatusIndex.com is an informational resource. FDA status, availability, and pricing should be independently verified using official FDA resources, pharmacy data, prescribing information, and licensed healthcare guidance.

FDA / regulatory source
https://www.fda.gov/media/71494/download?attachment=
Pricing source
https://www.goodrx.com/focalin

Preview this drug-status page

Use this button to preview the generated LPagery page for Focalin and confirm the page output before wider publishing.

Preview Page →
Informational resource only
DrugStatusIndex.com reflects publicly available FDA regulatory data and does not provide medical advice, diagnosis, treatment recommendations, pharmacy recommendations, or legal/regulatory advice. Always consult a licensed healthcare provider before making any medical decision.
Scroll to Top